You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1388-ESGO Comparison of disease free interval among cervical cancer patients who underwent concurrent chemoradiation for 10 years at a single institution in Korea; What about cervical adenocarcinoma?

Alerts

Article menu

Download PDFPDF

Cervical cancer
2022-RA-1388-ESGO Comparison of disease free interval among cervical cancer patients who underwent concurrent chemoradiation for 10 years at a single institution in Korea; What about cervical adenocarcinoma?
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address